Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
about
Rising health care costs and life-cycle management in the pharmaceutical marketDrug Pricing Evolution in Hepatitis CTrans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelines.Strategies that delay or prevent the timely availability of affordable generic drugs in the United StatesImpact of the introduction of mandatory generic substitution in South Africa: private sector sales of generic and originator medicines for chronic diseases.Designing economic evaluations to facilitate optimal decisions: the need to avoid bias.Branded prescription drug spending: a framework to evaluate policy options.Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.Dealing with the spiralling price of medicines: issues and solutions.Healthcare innovation and patent law's 'pharmaceutical privilege': is there a pharmaceutical privilege? And if so, should we remove it?
P2860
Q28533867-913AE17C-3312-47F1-BF7D-894935B8547EQ28550311-FD3FABC3-BD8D-43A0-8A70-9002C4AB6288Q35949251-388CF285-A2EC-40E4-9227-9A8D45B2BD8CQ36924615-23D6C0BD-AEC0-459C-AFB9-13D92632B1D6Q37026035-38DC655C-1069-412E-B28F-12BC2EFB7F3CQ39348676-9A856434-A225-46CC-AD34-0D0642A9CD98Q40038632-FA5951E0-B187-4836-B4E4-09C10973DC4DQ42284328-0DCE9794-54BC-49F1-97F7-B93CBC5C5C9BQ48314103-F79120AB-4E2E-4683-9727-E005F9307E5AQ50080930-B297ABF5-2662-490C-9F79-7377946437C1Q52810242-E07D6B10-7515-47BF-9711-197BC9F8BDD7
P2860
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
@ast
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
@en
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
@nl
type
label
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
@ast
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
@en
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
@nl
prefLabel
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
@ast
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
@en
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
@nl
P2093
P2860
P3181
P1433
P1476
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
@en
P2093
Daniel Muscionico
François Girardin
Guy Haller
Jean-Luc Salomon
Nathalie Vernaz
Pascal Bonnabry
Pierre Dayer
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1001460
P407
P577
2013-01-01T00:00:00Z